Creative Planning

SEC CIK: 0001540235
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overview All 13F holders of CRVS Full Q2 2026 holdings

Shares (Q2 2026): 42,174
Value: $630.1K
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2025

Holdings of CRVS by Creative Planning, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	42,174	$630.1K	<0.1%	−858−2.0%	Reduced	Holders
Q1 2026	43,032	$629.6K	<0.1%	+3,854+9.8%	Added	Holders
Q4 2025	39,178	$301.7K	<0.1%	+13,879+54.9%	Added	Holders
Q3 2025	25,299	$186.5K	<0.1%	+25,299	New	Holders